Steven Pieper, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 45,000 shares at $8.50 ($383K) on 2026-07-06, disclosed to the SEC on 2026-07-07.
Scheduled sale ($383k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 17,400 | $148K | 38.6% |
| 2 | $8.52 | 27,600 | $235K | 61.4% |
| Total | $8.52 avg | 45,000 | $383K | 100% |
| Filing → |
| XERS | SELL | 2026-08-12 | $43K | — | Filing → |
| XERS | BUY | 2023-11-21 | $55K | — | Filing → |
| XERS | BUY | 2021-11-12 | $50K | — | Filing → |